Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer
- 31 May 1993
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 47 (5) , 427-444
- https://doi.org/10.1016/0010-7824(93)90095-o
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Characteristics Relating to Ovarian Cancer Risk: Collaborative Analysis of 12 US Case -Control StudiesAmerican Journal of Epidemiology, 1992
- GnRH agonists as contraceptive agents: Predicted significantly reduced risk of breast cancerContraception, 1991
- Oral contraceptives and breast cancer review and meta-analysisCancer, 1990
- Cell Proliferation in CarcinogenesisScience, 1990
- The effect of age and menstrual cycle upon proliferative activity of the normal human breastBritish Journal of Cancer, 1988
- Combination Oral Contraceptive Use and the Risk of Endometrial CancerJAMA, 1987
- Age-related factors in cancers of the breast, ovary, and endometriumJournal of Chronic Diseases, 1987
- A Correlative Morphologic Study of Human Breast and Endometrium in the Menstrual CycleThe American Journal of Surgical Pathology, 1986
- Cell turnover in the “resting” human breast: influence of parity, contraceptive pill, age and lateralityBritish Journal of Cancer, 1982
- Cell proliferation in fibrocystic disease and postmenopausal breast ducts measured by thymidine labelingCancer, 1982